Virtual reality could help young cancer survivors navigate life after treatment

NCT ID NCT07571499

Not yet recruiting Knowledge-focused Sponsor: Gustave Roussy, Cancer Campus, Grand Paris Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a digital tool called TRANSCEND-XR that uses extended reality (like virtual reality) to help adolescents and young adults who have finished treatment for testicular cancer. The tool aims to teach them about long-term side effects, when to see a doctor, and how to stay healthy. Researchers will first test if the tool is easy to use, then compare it to standard follow-up care in 245 participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: extended reality digital educational tool
What this could lead to: If successful, this could provide a new way to help young testicular cancer survivors better understand their long-term health needs and take an active role in follow-up care.
What could go wrong: This is an early-stage study testing feasibility and knowledge improvement, not a treatment. The tool may not significantly change health outcomes or be widely adopted.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AYA CANCER SURVIVORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

testicular cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AYA CANCER SURVIVORS SURVIVOR PATIENTS TESTICULAR CANCER TESTIS CANCER

More trials for these conditions

Other studies related to the condition(s) this trial covers.